LEXEO Therapeutics
Aashir Khan works as a Clinical Science Associate at LEXEO Therapeutics since March 2022. Prior to that, at NewYork-Presbyterian Hospital since March 2020, Aashir was employed as a Hospital Pharmacist.
This person is not in the org chart
LEXEO Therapeutics
LEXEO Therapeutics is a New York City-based, fully integrated biotechnology company currently headquartered at the Alexandria Center® for Life Science that aims to apply the transformational science of gene therapy to address some of the world’s most devastating genetic and acquired diseases. LEXEO Therapeutics’ pipeline consists of adeno-associated virus (AAV)-mediated therapies primarily developed at Weill Cornell Medicine’s Department of Genetic Medicine.